Lombard Odier Asset Management (Usa) Corp Catalent, Inc. Transaction History

Lombard Odier Asset Management (Usa) Corp

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$31.86 - $67.26 $334,530 - $706,230	10,500 New	10,500 $455,000
Q3 2018 Nov 14, 2018	SELL	$40.12 - $45.55 $5.62 Million - $6.38 Million	-140,000 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$38.72 - $42.52 $2.13 Million - $2.34 Million	55,000 Added 64.71%	140,000 $5.87 Million
Q1 2018 May 15, 2018	SELL	$39.4 - $47.39 $922,393 - $1.11 Million	-23,411 Reduced 21.59%	85,000 $3.49 Million
Q4 2017 Feb 13, 2018	SELL	$37.27 - $43.02 $1.75 Million - $2.02 Million	-46,935 Reduced 30.21%	108,411 $4.45 Million
Q3 2017 Nov 14, 2017	BUY	$33.75 - $41.67 $5.24 Million - $6.47 Million	155,346	155,346 $6.2 Million

513

149M

575K

2.03M

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Lombard Odier Asset Management (Usa) Corp, based on Form 13F filings with the SEC.

Stay updated on Lombard Odier Asset Management (Usa) Corp with notifications on news.